Live Breaking News & Updates on Trial Thrombosis Predictors

Stay updated with breaking news from Trial thrombosis predictors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

VIVA23 Presents Outcomes of Late-breaking Science from Abbott's LIFE-BTK, RESOLV FIH Study, and IN.PACT AV Access Trial

The second round of late-breaking clinical trials were presented with results from three studies during the Vascular InterVentional Advances Conference, VIVA23, being held Oct. 30-Nov. 2 in Las Vegas, NV. Notably, results from Abbott’s LIFE-BTK randomized clinical trial (RCT) demonstrated that Esprit BTK (Abbott) reduces disease progression and helps improve medical outcomes compared to balloon angioplasty, the current state of care. ....

San Francisco , United States , New Zealand , Marianne Brodmann , Robert Lookstein , Raghu Kolluri , Wynn Las Vegas , Vascular Interventional Advances Conference , Controlled Trial Evaluating , Eluting Resorbable Scaffold , Transcatheter Cardiovascular Therapeutics , Infrapopliteal Artery , New England Journal , Month Results , Rutherford Classification , Trial Thrombosis Predictors , Vascular Interventional Advances ,